Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Drug Design, Development and Therapy|March 16, 2013
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosisJ William L Brown, Alasdair J ColesExpert Review of Neurotherapeutics|December 23, 2015
The role of MRI in the evaluation of secondary progressive multiple sclerosisJ William L Brown, Declan T ChardPostgraduate Medical Journal|April 17, 2023
Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemicTagore Nakornchai, Elena Conci, Anke Hensiek, et al.Brain : a Journal of Neurology|April 20, 2021
Surface-in pathology in multiple sclerosis: a new view on pathogenesis?Matteo Pardini, J William L Brown, Roberta Magliozzi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2024
Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trialChristopher E McMurran, Trisha Mukherjee, J William L Brown, et al.Circulation. Cardiovascular Quality and Outcomes|July 26, 2012
Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysisYoon K Loke, J William L Brown, Chun Shing Kwok, et al.Epilepsia|February 15, 2011
Amphetamine-associated seizures: clinical features and prognosisJ William L Brown, John W Dunne, Daniel M Fatovich, et al.Nature Reviews. Neurology|November 27, 2025
Towards primary prevention of multiple sclerosisRuth Dobson, Karim L Kreft, Benjamin M Jacobs, et al.BMJ Neurology Open|February 23, 2024
Visual outcome measures in clinical trials of remyelinating drugsGioia Riboni-Verri, Benson S Chen, Christopher E McMurran, et al.Journal of Neuroimmunology|April 8, 2014
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitisJ William L Brown, Peter J Martin, John W Thorpe, et al.Pageof 4